| The evolving landscape of drug products containing nanomaterials in the United States SR D'Mello, CN Cruz, ML Chen, M Kapoor, SL Lee, KM Tyner Nature nanotechnology 12 (6), 523-529, 2017 | 325 | 2017 |
| A review of intranasal formulations for the treatment of seizure emergencies M Kapoor, JC Cloyd, RA Siegel Journal of Controlled Release 237, 147-159, 2016 | 152 | 2016 |
| Covalent attachment of proteins to functionalized polypyrrole-coated metallic surfaces for improved biocompatibility W Khan, M Kapoor, N Kumar Acta biomaterialia 3 (4), 541-549, 2007 | 129 | 2007 |
| Compositions for nucleic acid delivery M Manoharan, KG Rajeev, M Jayaraman, D Butler, M Kapoor, ... US Patent 9,687,550, 2017 | 118 | 2017 |
| Liposomal drug product development and quality: current US experience and perspective M Kapoor, SL Lee, KM Tyner The AAPS journal 19, 632-641, 2017 | 89 | 2017 |
| Physicochemical characterization techniques for lipid based delivery systems for siRNA M Kapoor, DJ Burgess, SD Patil International journal of pharmaceutics 427 (1), 35-57, 2012 | 81 | 2012 |
| Efficient and safe delivery of siRNA using anionic lipids: formulation optimization studies M Kapoor, DJ Burgess International journal of pharmaceutics 432 (1-2), 80-90, 2012 | 71 | 2012 |
| Cellular Uptake Mechanisms of Novel Anionic siRNA Lipoplexes M Kapoor, DJ Burgess Pharmaceutical research, 1-15, 2012 | 32 | 2012 |
| Physicochemical characterization of anionic lipid-based ternary siRNA complexes M Kapoor, DJ Burgess Biochimica et Biophysica Acta (BBA)-Biomembranes 1818 (7), 1603-1612, 2012 | 32 | 2012 |
| Rapid Delivery of Diazepam from Supersaturated Solutions Prepared Using Prodrug/Enzyme Mixtures: Toward Intranasal Treatment of Seizure Emergencies M Kapoor, T Winter, L Lis, GI Georg, RA Siegel The AAPS Journal, 2014 | 20 | 2014 |
| Prodrug/Enzyme Based Acceleration of Absorption of Hydrophobic Drugs: An in Vitro Study M Kapoor, RA Siegel Molecular pharmaceutics 10 (9), 3519-3524, 2013 | 19 | 2013 |
| Water-soluble benzodiazepine prodrug/enzyme combinations for intranasal rescue therapies RA Siegel, M Kapoor, N Cheryala, GI Georg, JC Cloyd Epilepsy & Behavior 49, 347-350, 2015 | 14 | 2015 |
| Chirally pure prodrugs and their converting enzymes lead to high supersaturation and rapid transcellular permeation of benzodiazepines M Kapoor, N Cheryala, D Rautiola, GI Georg, JC Cloyd, RA Siegel Journal of Pharmaceutical Sciences 105 (8), 2365-2371, 2016 | 7 | 2016 |
| Targeted delivery of nucleic acid therapeutics via nonviral vectors M Kapoor, DJ Burgess Targeted Drug Delivery: Concepts and Design, 271-312, 2015 | 7 | 2015 |
| Compositions for nucleic acid delivery M Manoharan, KG Rajeev, M Jayaraman, D Butler, M Kapoor, ... | 2 | 2011 |
| Regulatory Considerations for Cancer Drug Products Containing Nanomaterials M Kapoor, K Hughes, KM Tyner Nanotheranostics for Cancer Applications, 277-299, 2019 | 1 | 2019 |
| Bernstein polynomial: a comprehensive review VJM Kapoor, V Joshi Int J Res Anal Rev (IJRAR) 5 (4), 214-219, 2018 | 1 | 2018 |
| Quantum dot labeling for assessment of intracellular trafficking of therapeutically active molecules DJ Burgess, M Kapoor Organelle‐Specific Pharmaceutical Nanotechnology, 535-567, 2010 | 1 | 2010 |
| Therapeutic compounds and formulations for intranasal delivery RA Siegel, M Kapoor, N Cheryala, GI Georg, JC Cloyd US Patent 10,682,310, 2020 | | 2020 |
| Drug delivery method RA Siegel, J Cloyd, T Winter, M Kapoor US Patent App. 16/161,850, 2019 | | 2019 |
Ronald A. SiegelProfessor of Pharmaceutics and Biomedical Engineering, University of MinnesotaBestätigte E-Mail-Adresse bei umn.edu
